Consult Semaglutide
GLP-1 receptor agonist — mimics the incretin hormone GLP-1, reducing appetite centrally, slowing gastric…
Every entry carries an evidence grade so you know exactly where the science stands. Research-use compounds can be purchased directly; clinical and prescription-tier compounds are gated behind a consultation.
Popularity is not proof. These grades are applied consistently across the whole library.
Approved by the FDA for at least one indication. Extensive human safety data.
Published human clinical trials exist, but no FDA approval for the relevant use.
Regulatory approval in other countries but not in the US.
Animal or in-vitro studies only. Promising but unproven in humans.
User reports and practitioner experience only. No controlled studies.
Consult GLP-1 receptor agonist — mimics the incretin hormone GLP-1, reducing appetite centrally, slowing gastric…
Consult Dual GIP/GLP-1 receptor agonist — activates both incretin pathways for enhanced metabolic effect beyond G…
Consult GLP-1 receptor agonist — same class as semaglutide but shorter half-life requiring daily dosing.
Research-use Triple agonist (GLP-1 + GIP + glucagon receptor) — activates all three incretin/metabolic pathways simult…
Consult Growth hormone-releasing hormone (GHRH) analog — stimulates pituitary GH secretion, preserving pulsatile…
Consult Melanocortin-4 receptor agonist — acts centrally on hypothalamic pathways involved in sexual arousal, dis…
Consult Exogenous testosterone — a steroid hormone, not a peptide, but commonly discussed alongside peptide proto…
Consult GHRH analog (residues 1-29) — stimulates endogenous GH release from the pituitary, maintaining physiologi…
Research-use Derived from gastric juice protein BPC. Proposed mechanisms include upregulation of growth factor recepto…
Research-use Synthetic fragment of thymosin beta-4 — promotes cell migration, angiogenesis, and anti-inflammatory effe…
Research-use Naturally occurring tripeptide-copper complex. Stimulates collagen synthesis, glycosaminoglycan productio…
Research-use Modified GHRH analog with Drug Affinity Complex (DAC) extending half-life to 6–8 days. Stimulates sustain…
Research-use Selective growth hormone secretagogue — activates ghrelin receptor (GHS-R1a) to stimulate GH release with…
Research-use Non-peptide ghrelin receptor agonist — oral GH secretagogue that increases GH and IGF-1 without injection…
Research-use Non-selective melanocortin receptor agonist — activates MC1R (pigmentation), MC3R/MC4R (sexual function,…
Research-use Thymic peptide — enhances T-cell maturation, dendritic cell function, and NK cell activity. Modulates Th1…
Research-use Synthetic tetrapeptide (Ala-Glu-Asp-Gly) studied by Khavinson. Proposed to activate telomerase in somatic…
Research-use A 16-amino-acid mitochondrial-derived peptide encoded within the mtDNA 12S rRNA. It signals from the mito…
Research-use Synthetic analog of immunoglobulin G fragment (tuftsin) — modulates serotonin, dopamine, and BDNF express…
Research-use Synthetic analog of ACTH(4-10) — enhances BDNF and NGF expression, modulates dopamine and serotonin syste…